Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

  • This share is currently suspended. It was suspended at a price of 81.80
  • There is currently no data for RNO

AGM Statement and Interim Management Statement

22 Jul 2014 07:00

RNS Number : 9489M
Renold PLC
22 July 2014
 



Renold plc

("Renold", "the Company" or "the Group")

 

AGM Statement and Interim Management Statement

 

Renold, a leading international supplier of industrial chains and related power transmission products, today issues its interim management statement covering the period from 1 April 2014 to the current date.

 

Strategic update

The final significant steps of the Bredbury closure project were completed during the first quarter as planned. The annualised savings arising from the project of £3.2m are in line with expectations and delivery has commenced slightly earlier than expected. Completion of the project will now allow more management time to be focussed on other continuous improvement initiatives to lower the Group's cost base further.

 

Financial update

Underlying (1) group revenue in the first quarter was 0.9% above the same period in the prior year. This reflects an improving trend relative to the 2.3% underlying revenue contraction in the first half of the prior year and the 0.8% contraction in the second half. The growth in the first quarter of the current year was driven by a combination of absolute growth in the Chain division and a further reduction in the rate of decline in Torque Transmission.

 

The combination of the early delivery of savings from the Bredbury factory closure, and other ongoing incremental actions to reduce the Group's breakeven point, have resulted in the Board's current expectations for the full year adjusted operating profit being above the current range of market forecasts, despite the adverse impact of foreign exchange movements.

 

There have been no other significant changes in the position of the Company over the period since the publication of the full year results for the year ended 31 March 2014.

 

Robert Purcell, Chief Executive of Renold, said:

"By completing the Bredbury closure project ahead of schedule we have accelerated the delivery of the resulting savings and also freed up management time to focus on new continuous improvement initiatives for the business. Self-help measures remain our priority and we are well placed to deliver further ongoing improvements in operational efficiencies and business processes which will generate additional reductions in our cost base."

 

22 July 2014

 

(1) The use of "underlying" excludes the impact of changes in foreign exchange rates.

 

ENQUIRIES:

 

Renold plc

0161 498 4500

Robert Purcell, Chief Executive

Brian Tenner, Finance Director

Arden Partners

020 7614 5917

Chris Hardie

Instinctif Partners

020 7457 2020

Mark Garraway

Helen Tarbet

  

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGUGDRGXDBGSD
Date   Source Headline
25th Aug 20217:00 amRNSHolding(s) in Company
23rd Aug 202112:11 pmRNSResult of AGM
23rd Aug 20217:00 amRNSAGM Trading Update
12th Aug 20214:40 pmRNSSecond Price Monitoring Extn
12th Aug 20214:35 pmRNSPrice Monitoring Extension
29th Jul 20214:41 pmRNSSecond Price Monitoring Extn
29th Jul 20214:36 pmRNSPrice Monitoring Extension
28th Jul 20217:00 amRNSPosting of Annual Report and Notice of AGM
27th Jul 202112:50 pmRNSDirector/PDMR Shareholding
26th Jul 20218:55 amRNSGrant of Options
19th Jul 202111:23 amRNSDirector/PDMR Shareholding
16th Jul 20217:00 amRNSFinal Results
13th Jul 20217:00 amRNSFlexible Coupling Contract Award
8th Jul 20219:47 amRNSNotice of results for the year ended 31 March 2021
23rd Jun 20213:30 pmRNSHolding(s) in Company
18th Jun 20217:00 amRNSBlock listing Six Monthly Return
16th Jun 20217:00 amRNSNotice of results for the year ended 31 March 2021
15th Jun 20214:40 pmRNSSecond Price Monitoring Extn
15th Jun 20214:35 pmRNSPrice Monitoring Extension
11th Jun 20217:00 amRNSInvestor Presentation – 17 June 2021
28th May 202112:35 pmRNSNotice of Results
27th May 20214:02 pmRNSCapital Reduction
26th May 20218:30 amRNSPreference Stock Dividend
4th May 202110:38 amRNSHolding(s) in Company
15th Apr 20215:27 pmRNSResults of General Meeting
14th Apr 20217:00 amRNSTrading Update for the year ended 31 March 2021
29th Mar 20218:40 amRNSNotice of General Meeting
24th Feb 20215:17 pmRNSHolding(s) in Company
9th Feb 20214:37 pmRNSHolding(s) in Company
5th Feb 202112:26 pmRNSHolding(s) in Company
29th Jan 20217:00 amRNSHolding(s) in Company
13th Jan 20217:00 amRNSTrading Update
17th Dec 20207:00 amRNSBlock listing Interim Review
26th Nov 20207:00 amRNSPreference Stock Dividend
23rd Nov 20204:15 pmRNSHolding(s) in Company
20th Nov 20207:00 amRNSAppointment of Non-Executive Director
18th Nov 20204:15 pmRNSHolding(s) in Company
16th Nov 20207:00 amRNSGrant of Awards – Performance Share Plan
11th Nov 20207:00 amRNSHalf-year Report
16th Oct 20207:00 amRNSTrading Update
1st Oct 20208:41 amRNSGrant of Awards - Performance Share Plan
24th Sep 20207:00 amRNSRe: Directorate Change
22nd Sep 20203:20 pmRNSDirector/PDMR Shareholding
18th Sep 20203:50 pmRNSDirector/PDMR Shareholding
11th Aug 20207:00 amRNSPDMR/Directorate Change
24th Jul 20201:23 pmRNSResult of AGM
24th Jul 20207:00 amRNSAGM Statement
26th Jun 20202:57 pmRNSAnnual Report and Accounts
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:37 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.